July 26, 2013 — Worldwide healthcare cognitive computing markets are poised to achieve continuing growth as the healthcare delivery system responds to new products. Growth is achieved in response to changing technology, better analytics, new information systems that leverage natural language and changing market conditions.
Healthcare decision support markets consist of traditional market participants led by McKesson and Watson from IBM. IBM Watson offers structured and unstructured data in combination. This represents a major breakthrough in what kind of decision support can be offered.
IBM Watson can provide a far more differentiated testing assessment and knows what tests are relevant to further characterize a particular patient condition and what tests are not. Having an assistant that is able to have read the latest journal articles and is loaded with medical information to recommend what tests may be relevant in a particular situation is a great help to physicians. Wrong tests, tests that are not useful in a particular situation, account for 30 percent of the costs of healthcare delivery in the United States.
IBM Watson is initiating a new era of cognitive computing that extends the tabulator and application program intensive enabling new market opportunities based on cognitive performance. Watson is comprised of a powerful core engine. The first purpose that Watson has been put to is to improve healthcare delivery.
For more information: www.researchandmarkets.com/research/v5ccjm/healthcare